期刊文献+

Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers 被引量:1

原文传递
导出
摘要 The main purpose of this study was to evaluate the pharmacokinetics of levosulpiride in humans after single and multiple intramuscular injections.Six males and six females received single dose of either 25 mg or 50 mg levosulpiride,or multiple doses of 25 mg every 12 h for 5 consecutive days.In the single 25 mg study,the mean peak plasma concentration(C max)was 441 ng/mL,the mean area under the concentration–time curve from 0 to 36 h(AUC_(0–36))was 1724 ng h/mL,and the mean elimination half-life(t_(1/2))was 7.0 h.In the single 50 mg study,the mean C max was 823 ng/mL,the mean AUC_(0–36) was 3748 ng·h/mL,and the mean t_(1/2) was 6.8 h.After multiple doses of 25 mg levosulpiride,the average plasma concentration(C av)was 136 ng/mL,the fluctuation index(DF)was 3.60,and the accumulation ratio(R)was 1.2.Levosulpiride injections appeared to be well tolerated by the subjects,and can be used for successive administration.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS 2014年第5期402-407,共6页 药学学报(英文版)
  • 相关文献

参考文献1

二级参考文献8

  • 1Davis KL, Nappi JM. The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist [J]. Clin Ther, 2003, 25: 2647-2668.
  • 2Zhang JY, Fast DM, Breau AE Development and validation of a liquid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma [J]. J Chromatogr B, 2003, 787: 333-344.
  • 3Cook CS, Zhang LM. lnterconversion pharmacokinetics of eplerenone, a selective aldosterone blocker, and its lactonering open form [J]. J Pharm Sci, 2002, 91:1383-1389.
  • 4Cook CS, Berry LM, Bible RH. Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans [J]. Drug Metab Dispos, 2003, 31: 1448-1455.
  • 5Ravis WR, Reid S, Sica DA, et al. Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment [J]. J Clin Pharmacol, 2005, 45 810-821.
  • 6Meineke I, Gleiter CH. Assessment of drug accumulation in the evaluation of pharmacokinetic data [J]. J Clin Pharmacol, 1998, 38: 680-684.
  • 7Ding L, Li L, Ma PC. Determination of azelnidipine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry [J]. J Pharm Biomed Anal, 2007, 43: 575-579.
  • 8Zhao LH, Ding L, Wei X. Determination of moxonidine in human plasma by liquid chromatography-electrospray ionisation-mass spectrometry [J]. J Pharm Biomed Anal, 2006, 40: 95-99.

共引文献6

同被引文献3

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部